Jubilant HollisterStier

Jubilant HollisterStier opened a third manufacturing line at its Spokane factory, adding 50,000 square feet and over 200 jobs. The expansion increases production capacity by 55 million units per year.

Jubilant HollisterStier announced the appointment of Chris Preti as President, effective March 2023.

Jubilant HollisterStier is investing ~$285 million to double its capacity for fill and finish of sterile injectables at its Spokane, Washington facility. The expansion is progressing well.

Jubilant HollisterStier LLC entered a $149.6 million cooperative agreement with the US government to double injectable filling production capacity at its Spokane, Washington facility, to be completed by 2025.

Jubilant HollisterStier is investing ~$285 million to double its capacity for fill and finish of sterile injectables at its Spokane, Washington facility, with $149.6 million from the US government.

Jubilant HollisterStier will supply the COVID-19 vaccine Covaxin from its Spokane, Washington facility for Ocugen. The contract supports potential commercialization in the US and Canada.

Jubilant HollisterStier announced a $92 million investment to expand sterile injectable manufacturing capacity at its Spokane, Washington facility, adding a high-speed fill line and lyophilizers, to be commercially operational by end of 2024.